health corp expert
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
he does this often..........wonder why?
Check out their web site. New news. It's dated October first. So must be going out on Monday. Good stuff. Surprising though it's not about India or Canada. Sounds like a very strong marketing company with significant contacts and influence. And they cover most of middle east and North Africa.
http://www.alrt.com/news/2018/10/01/alrt-and-ideas-dwc-market-alrt-diabetes-solution-in-middle-east-and-north-africa
ALR TECHNOLOGIES AND IDEAS DWC LLC TO MARKET THE ALRT DIABETES SOLUTION IN THE MIDDLE EAST AND NORTH AFRICA
ALRT’s comprehensive diabetes management system could improve outcomes and provide diagnostic tools for diabetes therapies in one of the world’s most critical diabetes markets
(October 1, 2018 -- RICHMOND, VA) ALR Technologies Inc. (OTCPINK: ALRT) has signed a Collaboration Agreement with IDEAS DWC LLC. (“IDEAS”), a Dubai-based marketing company, to bring the ALRT Diabetes Solution to the estimated 40 million people with diabetes in the Middle East and North Africa (MENA) region. The International Diabetes Foundation reports that this regional area has the highest prevalence of diabetes in the world. The initial focus will be the Gulf Cooperation Council countries, specifically UAE, Saudi Arabia and Kuwait.
Under the terms of the agreement, IDEAS will conduct all business activities on behalf of ALRT in the region and ALRT will provide all necessary support to IDEAS.
Presentations have been made in Dubai to hospital and health groups and additional meetings are planned with Dubai and UAE health authorities.
“This agreement will give ALRT access to markets with growing diabetes prevalence through established professionals in the local markets,” said Sidney Chan, Chairman and CEO of ALR Technologies Inc. “This will increase ALRT’s marketing reach while helping to improve delivery of best practice diabetes care and patient outcomes in one of the world’s most critical diabetes markets.”
“With direct access to medical and health government authorities, close collaborations to more than 50 major medical chains and all major insurance companies in the region, IDEAS can advance ALRT’s business to a new level.” said Marian Han, Vice President of IDEAS DWC LLC.
MENA countries defined in the Collaboration Agreement include: Afghanistan, Algeria, Bahrain, Egypt, Iran, Iraq, Jordan, Kuwait, Lebanon, Libya, Morocco, Oman, Pakistan, Palestine, Qatar, Saudi Arabia, Sudan, Syria, United Arab Emirates and Yemen
About ALR Technologies Inc.
ALR Technologies is a medical device company that developed the ALRT Diabetes Solution, a comprehensive approach to diabetes care that includes: an FDA-cleared and HIPAA compliant diabetes management system that collects data directly from blood glucose meters; a patent pending Predicative A1C to track treatment success between lab reports; FDA-cleared Insulin Dosing Adjustment that suggests insulin dosing changes to optimize drug therapy; and, performance tracking to ensure best practices are followed. Currently, the Company is focused on diabetes and will expand its services to cover other chronic diseases anchored on verifiable data. More information about ALR Technologies, Inc. can be found at www.alrt.com.
About IDEAS DWC LLC
IDEAS DWC LLC (IDL) is a subsidiary of IGC (IDEAS Group of Companies) - a global investment group with portfolios in different regions with core business in asset management, resource collaborations and government advisory member. Located in Dubai, IDL is specialized in marketing and consulting with profound connections with different parties in the MENA region: royal families, government bodies, business conglomerates, celebrities, influencers and more. In medical and health industry, IDEAS has been evolving in projects bridging gaps of technology, products and the market with innovative business models and collaborations to leverage the powers and resources of different parties for multi-lateral success.
on one of their recent news releases they stated they had agreements with 3 current manufacturers of meters and I guess the test strips. So alrt would not be manufacturing their own They didn't announce which companies but two of the big ones are J&J and Bayer. They mentioned bundling for the reimbursement.......which I think is brilliant
no device.......it's a software platform---cost of goods practically 0
Will take news of a contract for a breakout. Then the breakout will be siignificant. IMO
That company type of app is nothing new. ALRT is several steps ahead of that type of app. ALRT also is a platform that allows for remote diabetes management and decision making by the providers for early detection and changes in care plan.
Srini, I like your "2 cents worth". Yes, with the network connections that Aspire has I would think we'll see usage of the ALRT platform soon. Why not start helping Diabetes patient while lowering cost of care. THIS IS THE ULTIMATE. Once many in India start understanding the potential of ALRT I would expect a lot of stock buying. Not sure where the price would go but could approach $0.50 PPS next week. My opinion. And I know a lot of govt health plans that should be buying into this diabetes management platform. Will be nice when we see 20 million diabetes patients on this. You mentioned Canada, Dubai, Chile, etc. Exciting.
apparently stock buyers are waiting to see news of a deal with a company that is going to use the product, not just agreeing to co-market. Hopefully this group in India has some companies ready to sign on for using/buying. and hopefully Canada will soon sign on to use the product.
To me the stock is way undervalued now given the news, but I guess most potential buyers want to know that company or healthplan will actually pay for the ALRT service. they should, the benefits to cost reduction and to patient outcome are tremendous. IMHO
appears too many shareholders wanting to sell at these low prices. Go figure. They just need a little due diligence.
great point......Amazon or Google. they both want more connections and both are into health care now. Let's get investors in India into this stock somehow. Wonder if this news hits over there.
the perfect question. Even 1% of the India market is huge. I hope this news gets into the investor blogs and sites in India. A lot of money over there and those individuals or companies would better understand the need for the ALRT system in India and the potential. That could spark a lot of stock buying from the executives in India.
exciting. And it reads that this Aspire company is also in North America. Wonder if that means Canada. And it says 100 million in India with Diabetes. I think the real number is about 200 million. 100 million receiving treatment. But so many people cannot afford treatment.
SO IF---AND I DO MEAN SO IF; 5% end up getting the ALRT system and ALRT has said they expect about $10 per month per patient, that would be $50 million per month and most of that should be profit because it's software/internet platform. My math then shows it about $600 million a year in India alone. Wonder how fast these things can happen though. My best guess is that some big pharma or private equity firm will try to buy them out soon. Or maybe a Google. That makes sense.
I recall that Friday morning was much the same as all week UNTIL Last One Sitting sent out those retweets from ALRT. Those retweets strongly suggested action happening or coming soon from Canada. Made for an interesting day but today is what I guess we're anticipating.
those tweets must be the driver in this action. No other news out yet that I've seen. And tweets coming from Canada is the key here. !!!!!!!
very interesting. Thanks Last One Sitting. Could this mean that the agreement with Alberta is all but signed!!! Hmmmmm-----this tweet makes it appear that way.
the business model is brilliant with the bundling agreements they have in place with 3 manufacturers, as per the last news release. And the need is clear with the epidemic of diabetes and the huge cost to healthcare and to society.. But where is the demand. Seems as though no company that will benefit knows about ALRT. Need some serious PR.
Go figure......now an insurance company can pay for all their blood sugar testing supplies and insulin along with the ALRT platform that comes with the remote management of patients. All for the same price as for the testing supplies and insulin alone.
Like I've said before I liken it to buying a car and you get a garage free, or just buying the exact same car and you don't get the garage.
The govt paid health plans should be jumping all over this. Where are they? Yes, Canada. Where are you? Yes, Chile---where are you? Yes, Medicaid and Medicare and Tricare--------where are you?
Definitely not a competitor. Actually this company and all blood glucose test and data companies would want to contract with ALRT to integrate with the ALRT platform. I think this is partly why we are not seeing any new stock buyers. Most people don't understand that ALRT is a platform that accumulates the data for providers and insurers and allows for remote care plan decision making guidance on medications, on patient adherence, on insulin guidance, A1c prediction, etc. Allowing for remote management of large scale populations and allowing for those with diabetes to be placed on the proper care plan is key to improving outcome and reducing cost.
ALRT is a great product(s), not crap. It's the ignorance or lack of knowledge of potential buyers that is crap. I've been holding for more than 10 years and continue to add to my holdings. This company has been way ahead of times and the healthcare decision makers hate change but they are finally seeing that the ALRT system will help patients, will help providers and lower cost to the payers.
this is penny crap......nothing at all going on.....if there was it would be going up .05 at a time and would be .25 by now. This is unbelievable to me. This company product's are worth millions in the healthcare marketplace. if any investor understood they would spend $20,000 and that alone would buy about 400,000 shares. Little less though because that should get the price up to around 0.12. IMO
Anyone have level II. Would love to know the amount of ask volume before the price is up to .10 or so.
means there is not sufficient awareness of the likely next steps and the potential. We should be seeing a couple million shares trading daily
Significant material events are required to be filed as an 8k in most cases, even if they were covered in a news release. This bundling of services is very brilliant......given that it will all be covered by the same reimbursement that covers the blood glucose test supplies alone.
Clearance is for medical equipment. Approval is for medications. But why did you bring this question up?
If potential buyers understand the magnitude the price would be in the .20s by now. looks like this news was not enough to impress---potential investors just don't understand........not yet, but soon. .
I guess it will take news of the contracts which surely will be announced soon.
no demand yet, no buyers
Wait till contracts are announced! Think of the attention and demand. And after a series of contracts.......!!!!
Their offering is a no-brainer for Health plans. All the extra services for no more cost that blood glucose testing equipment alone.
.40 and .45 sounds better
This i s incredible about the bundle and 3 manufacturers of blood glucose testing equipment and along with the move to Canada suggests that we should be hearing about contracts soon. Canada for one.
This bundle offering is perfect for Canada with their health system. And for the health insurance companies in the US........I would expect the diabetic medication manufacturers and the insulin manufacturers to see value in promoting use of this bundle offering. It will get patients on the proper care plan much earlier........thus stopping or slowing the progression of the disease while increasing the usage of the diabetes medication and insulin. Most patients are months behind where they should be on the care plan.
Incredible Development.yes,the cash bonus to patients for adherence but more importantly--If I read this correctly, ALRT is bundling their services with blood glucose testing equipment manufacturers and the insurance reimbursement for the equipment alone will pay for it all. What an incredible offering. So a health plan will have this scenario for a decision:
For about the same price:
choose either;
a. blood glucose testing equipment
OR
b. blood glucose testing equipment PLUS the services that the ALRT diabetes management platform provides.
This is incredible and brilliant. Obviously these blood glucose equipment manufacturers see the value in offering their equipment at a much lower price and I would think they know they will increase their sales and market share significantly with this bundle offer. Amazing.
an example is if you have a choice of buying an automobile from one distributor Or buy from a different distributor for the same price the same quality auto And you get a garage with it for no extra cost.
Incredible Development. If I read this correctly, ALRT is bundling their services with blood glucose testing equipment manufacturers and the insurance reimbursement for the equipment alone will pay for it all. What an incredible offering. So a health plan will have this scenario for a decision:
For about the same price:
choose either;
a. blood glucose testing equipment
OR
b. blood glucose testing equipment PLUS the services that the ALRT diabetes management platform provides.
This is incredible and brilliant. Obviously these blood glucose equipment manufacturers see the value in offering their equipment at a much lower price and I would think they know they will increase their sales and market share significantly with this bundle offer. Amazing.
an example is if you have a choice of buying an automobile from one distributor Or buy from a different distributor for the same price the same quality auto And you get a garage and house thrown in with it---for no extra cost.
They had previously announced that Canada was one of the 4 key target markets they were progressing with. This suggests to me they have reached a deal with Canada and as part of the negotiation they agreed to relocate. As such I would expect an announcement in the very near future about a contract/signing with Canada. IMO
Agreed. This is significant news. One of ALRT's initial target markets was Alberta Canada. This IMO strongly suggests that the deal is done and as such a move to Canada was either part of the deal and/or it just makes good business sense. IMO.......this does suggest the deal with Alberta or other in Canada is firmed up and hopefully will be soon announced. After a few announcements we could see $1 plus...IMO
I was thinking IMO the price would reach near $1 after the first partnership announcement but I'm now thinking it could be in the $2 to $4 range.......IMO.
agreed, but when? Need news badly to get momentum and then more news to keep the momentum and get the price up to where it really should be
this is funny. As stated before you understand nothing about building business and startups. Or investments. The money is owed to himself and his family. They have funded the company. And repayment timing is flexible. Revenue wills startup soon.
we are wasting time responding to Chicagojosh. He is jerking everyone's chain. Nothing he says is based on a realism......it's actually funny reading his BS.
Value comes from expected future earnings for a company in this stage. $25 million in debt is peanuts compared to the cash flow and earnings their platform can and will bring in, in my opinion. I've been working with healthcare market startups and financing for 30 years. Wonder why Chicago just now appeared? He's afraid of what ALRT might do. Time to completely ignore this guy.
Tesla has horrible financials. All companies do until they start commercialization. And ALRTs commercial potential is staggeringly positive. You clearly etiher are out to bash ALR or you know nothing about how valuations are determined for companies in the development stage. Many pharma companies have market caps in the hundreds of millions or billions before they make a first dollar of earnings.
great idea. I hope they all read the news release, and MOST DEFINITELY click on the link to the video. This video explains everything so well, and shows clearly why this platform is much needed.
The video that is linked to the news release is awesome. Everyone please watch. It show so clearly why there is the need and how the ALRT platform will reduce costs and get patients on more intensive care at the appropriate times. So easy to understand.
agreed, $0.20 is low once they announce the deals. Then I also see a dollar plus. i just think that even pre-deal announcements the expectation of deals looming around the corner will get the price moving nicely.
This news is better than good. IMO, they would not announce these market areas unless they were already well on their way to finalizing deals in those areas. As such, we should expect news on deals very soon. In advance of those, IMO, we'll see a price above $0.20. Thats my opinion based on what I know about the business of managing diabetes patients and the costs associated with their care. Self insured governments will love this disease management platform.
Preventing patients from getting too far damaged by diabetes and getting them on more intensive management to prevent all those co-morbidities, with this platform can save $billions in those areas they are targeting.